JB
Jason Butler JMP Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$452M
| $8.39 | $11 |
31%
upside
| Market Outperform | yesterday |
|
|
ABVX
2
Abivax
ABVX
$6.24B
| $82.54 | $95 |
15%
upside
| Market Outperform | 1 month ago |
|
|
RAPP
3
Rapport Therapeutics
RAPP
$589M
| $16.13 | $28 |
74%
upside
| Market Outperform | 1 month ago |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $25.96 | $37 |
43%
upside
| Market Outperform | 2 months ago |
|
5
GH Research
GHRS
$855M
| $13.79 | $39 |
183%
upside
| Market Outperform | 2 months ago |
|
6
Precigen
PGEN
$1.53B
| $5.15 | $6 |
17%
upside
| Market Outperform | 2 months ago |
|
7
Trade Desk
TTD
$26.4B
| $53.90 | $100 |
86%
upside
| Market Outperform | 3 months ago |
|
8
Viridian Therapeutics
VRDN
$1.61B
| $19.76 | $38 |
92%
upside
| Market Outperform | 3 months ago |
|
9
Cytokinetics
CYTK
$5.93B
| $49.53 | $78 |
57%
upside
| Market Outperform | 4 months ago |
|
|
10
Cytokinetics
CYTK
$5.93B
| $49.53 | $78 |
57%
upside
| Market Outperform | 5 months ago |
|
|
11
Precigen
PGEN
$1.53B
| $5.15 | $6 |
17%
upside
| Market Outperform | 5 months ago |
|
|
ABVX
12
Abivax
ABVX
$6.24B
| $82.54 | $33 |
60%
downside
| Market Outperform | 5 months ago |
|
13
Zevra Therapeutics
ZVRA
$519M
| $9.25 | $18 |
95%
upside
| Market Outperform | 5 months ago |
|
14
Esperion Therapeutics
ESPR
$466M
| $2.31 | $4 |
73%
upside
| Market Outperform | 6 months ago |
|
15
argenx
ARGX
$43.6B
| $711.63 | $701 |
1%
downside
| Outperform | 6 months ago |
|
|
16
Prothena Corp
PRTA
$452M
| $8.39 | $80 |
854%
upside
| Market Outperform | 6 months ago |
|
17
Dynavax Technologies
DVAX
$1.19B
| $10.13 | $33 |
226%
upside
| Market Outperform | 6 months ago |
|
18
Rezolute
RZLT
$627M
| $7.21 | $9 |
25%
upside
| Market Outperform | 6 months ago |
|
|
19
argenx
ARGX
$43.6B
| $711.63 | $696 |
2%
downside
| Market Outperform | 7 months ago |
|
20
Halozyme
HALO
$8.68B
| $74.20 | $73 |
2%
downside
| Market Outperform | 10 months ago |
|
21
Aquestive Therapeutics
AQST
$472M
| $3.90 | $9 |
131%
upside
| Market Outperform | 10 months ago |
|
|
22
Zevra Therapeutics
ZVRA
$519M
| $9.25 | $17 |
84%
upside
| Market Outperform | 11 months ago |
|
23
CorMedix
CRMD
$1.09B
| $14.60 | $19 |
30%
upside
| Market Outperform | 1 year ago |
|
24
Arbutus Biopharma
ABUS
$761M
| $3.97 | $9 |
127%
upside
| Market Outperform | 3 years ago |
|
|
25
Esperion Therapeutics
ESPR
$466M
| $2.31 | $111 |
4,705%
upside
| Market Outperform | 4 years ago |
|